Albright Charles 4
4 · Editas Medicine, Inc. · Filed Nov 10, 2020
Insider Transaction Report
Form 4
Albright Charles
Chief Scientific Officer
Transactions
- Sale
Common Stock
2020-11-09$31.21/sh−228$7,116→ 24,907 total
Footnotes (1)
- [F1]Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on May 11, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on November 6, 2020. The sale does not represent a discretionary trade by the Reporting Person.